SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (12305)12/8/1997 7:52:00 PM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
>>Andy, the number of shares short is not what is keeping the price down.The act of shorting can drop the price. In fact , sometimes a large short position in a stock can be good.<<

That much I understand. Are we agreed then that Farallon has no reason any more to keep the price of LGND down?



To: celeryroot.com who wrote (12305)12/8/1997 8:08:00 PM
From: Henry Niman  Respond to of 32384
 
Celeryroot, It looked like about 58,700 shares were used to cover the shares shorted on Oct 20, 21 and Nov 4 and 5. The additional shares were all delivered on 11/24 for earlier shorts. They add up to approximately 1.66 million (298,155 + 346,560 + 346,560 + 94,185 + 94,185 + 21,533 + 21,533 + 50,655 + 50,655 + 58,848 + 80,350 + 29,512 + 58,848 + 80,350 + 29,512).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News